1. A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109). Issue 2 (February 2015) Authors: Hattori, Yoshihiro; Satouchi, Miyako; Shimada, Temiko; Urata, Yoshiko; Yoneda, Tsutomu; Mori, Masahide; Nishimura, Takashi; Sunadome, Hironobu; Kumagai, Toru; Imamura, Fumio; Fujita, Shiro; Kaji, Reiko; Hata, Akito; Tachihara, Motoko; Morita, Satoshi; Negoro, Shunichi Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109). Issue 2 (February 2015) Authors: Hattori, Yoshihiro; Satouchi, Miyako; Shimada, Temiko; Urata, Yoshiko; Yoneda, Tsutomu; Mori, Masahide; Nishimura, Takashi; Sunadome, Hironobu; Kumagai, Toru; Imamura, Fumio; Fujita, Shiro; Kaji, Reiko; Hata, Akito; Tachihara, Motoko; Morita, Satoshi; Negoro, Shunichi Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations (JMTO LC12‐01). Issue 12 (13th May 2022) Authors: Asami, Kazuhiro; Ando, Masahiko; Nishimura, Takashi; Yokoi, Takashi; Tamura, Atsuhisa; Minato, Koichi; Mori, Masahide; Ogushi, Fumitaka; Yamamoto, Akiyoshi; Yoshioka, Hiroshige; Kawahara, Masaaki; Atagi, Shinji Journal: Thoracic cancer Issue: Volume 13:Issue 12(2022) Page Start: 1827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease：A case report. (2020) Authors: Kagawa, Hiroyuki; Tsujino, Kazuyuki; Yamamoto, Yuji; Iwai, Ami; Hara, Reina; Matsuki, Takanori; Fukushima, Kiyoharu; Oshitani, Yohei; Yoshimura, Kenji; Miki, Mari; Miki, Keisuke; Kitada, Seigo; Mori, Masahide; Kida, Hiroshi Journal: Respiratory medicine case reports Issue: Volume 29(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational study. (2016) Authors: Higashiguchi, Masayoshi; Kijima, Takashi; Morimura, Osamu; Osa, Akio; Suzuki, Hidekazu; Inoue, Takako; Kagawa, Hiroyuki; Ueno, Kiyonobu; Hirashima, Tomonori; Kumagai, Toru; Imamura, Fumio; Mori, Masahide; Tanio, Yoshiro; Kawase, Ichiro Journal: Cancer treatment communications Issue: Volume 5(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bronchial ethanol injection therapy for airway obstruction in lung cancer patients. Issue 9 (29th July 2021) Authors: Okabe, Fukuko; Yano, Yukihiro; Kuge, Tomoki; Uenami, Takeshi; Kanazu, Masaki; Mori, Masahide Journal: Respirology case reports Issue: Volume 9:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Case series of pleomorphic carcinomas of the lung treated with nivolumab. Issue 6 (7th September 2017) Authors: Kanazu, Masaki; Uenami, Takeshi; Yano, Yukihiro; Nakatsubo, Saeko; Hosono, Yuki; Ishijima, Mikako; Akazawa, Yuki; Yamaguchi, Toshihiko; Urasaki, Koji; Mori, Masahide; Yokota, Soichiro Journal: Thoracic cancer Issue: Volume 8:Issue 6(2017) Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report. Issue 5 (9th April 2019) Authors: Edahiro, Ryuya; Ishijima, Mikako; Kurebe, Hiroyuki; Nishida, Kohei; Uenami, Takeshi; Kanazu, Masaki; Akazawa, Yuki; Yano, Yukihiro; Mori, Masahide Journal: Thoracic cancer Issue: Volume 10:Issue 5(2019) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effectiveness of EGFR tyrosine kinase inhibitors in advanced non‐small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study. Issue 1 (29th October 2020) Authors: Kanazu, Masaki; Mori, Masahide; Kimura, Madoka; Nishino, Kazumi; Shiroyama, Takayuki; Nagatomo, Izumi; Ihara, Shoichi; Komuta, Kiyoshi; Suzuki, Hidekazu; Hirashima, Tomonori; Kumagai, Toru; Imamura, Fumio Journal: Thoracic cancer Issue: Volume 12:Issue 1(2021) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial. Issue 1 (17th May 2020) Authors: Arai, Toru; Kida, Hiroshi; Ogata, Yoshitaka; Marumo, Satoshi; Matsuoka, Hiroto; Gohma, Iwao; Yamamoto, Suguru; Mori, Masahide; Sugimoto, Chikatoshi; Tachibana, Kazunobu; Akira, Masanori; Inoue, Yoshikazu Journal: BMJ open respiratory research Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗